
Nikethamide is a central nervous system (CNS) stimulant that primarily acts as a respiratory stimulant. It was previously used in medicine to treat conditions like respiratory depression and to counteract the effects of barbiturate overdose. However, due to its side effects and potential for causing seizures, its medical use has been largely discontinued.
Nikethamide stimulates the medullary respiratory center, leading to increased respiration rate and depth. It may also have some cardiovascular stimulant effects. Unlike other stimulants such as caffeine or amphetamines, its primary action is on respiratory function rather than general arousal or alertness.
Nikethamide has been banned or discontinued in most countries due to safety concerns, particularly its potential to cause convulsions and its lack of effectiveness compared to modern alternatives. It is prohibited in competitive sports by the World Anti-Doping Agency (WADA).
Price: